نتایج جستجو برای: ccl2

تعداد نتایج: 3610  

Background: inflammatory chemokines such as CCL2 and CCL5 are involved in the progress of osteoarthritis. Crocin with antioxidant and anti-inflammatory properties can reduce the symptoms of osteoarthritis (OA). This study was performed investigate the effect of Krocina™, on the gene expressions and plasma levels of CCL2 and CCL5 in OA patients. Methods: The study included 35 patients that we...

ژورنال: :مجله دانشگاه علوم پزشکی ایلام 0
مژگان موگویی mozhgan moogooei department of immunology, rafsanjan university of medical sciences, rafsanjan, iran.گروه ایمنی شناسی ،ایران ،دانشگاه علوم پزشکی رفسنجان غلامحسین حسن شاهی gholamhossein hassanshahi molecular medicine research center, rafsanjan university of medical sciences, rafsanjan, iranمرکز تحقیقات سلولی و مولکولی،،دانشگاه علوم پزشکی رفسنجان حسین خرم دل آزاد hossein khorramdelazad molecular medicine research center, rafsanjan university of medical sciences, rafsanjan, iranمرکز تحقیقات سلولی و مولکولی،،دانشگاه علوم پزشکی رفسنجان مریم موگویی maryam moogooei department of immunology, shahid sadoughi university of medical sciences and health services, yazd, iran.گروه ایمنی شناسی ، دانشگاه علوم پزشکی شهید صدوقی شیرین فتاح پور shirin fattahpour department of biochemistry, rafsanjan university of medical sciences, rafsanjan, iran.، گروه بیوشیمی ، دانشگاه علوم پزشکی رفسنجان

مقدمه: شبکه پیچیده کموکاین ها و رسپتور آن ها نقش مهمی در گسترش و متاستاز تومورها دارد. این مطالعه به بررسی میزان بیان mrna ی ccr2 و ccr5 و هم چنین سطح سرمی ccl2 و ccl5 در بیماران مبتلا به کارسینوم سلول های ترانزیشنال مثانه قبل و بعد از عمل tur می پردازد. مواد و روش ها: در این تحقیق پیش رو 40 نفر بیمار مرد مبتلا به transitional cell carcinoma (tcc) و 40  نفر مرد سالم وارد مطالعه شدند. نمونه های ...

2017
Min Yao Curtis Smart Qingting Hu Nikki Cheng

Chemokines are small soluble molecules that play critical roles in wound healing, infection, and cancer progression. In particular, overexpression of the C-C motif chemokine ligand 2 (CCL2) in multiple cancer types correlates with poor patient prognosis. Animal studies have shown that CCL2 signals to macrophages and breast cancer cells to promote tumor growth, invasion, and metastasis, indicati...

2016
Ryuichiro Arakaki Toshinari Yamasaki Toru Kanno Noboru Shibasaki Hiromasa Sakamoto Noriaki Utsunomiya Takayuki Sumiyoshi Shinsuke Shibuya Tatsuaki Tsuruyama Eijiro Nakamura Osamu Ogawa Tomomi Kamba

We previously reported that the pVHL-atypical PKC-JunB pathway contributed to promotion of cell invasiveness and angiogenesis in clear cell renal cell carcinoma (ccRCC), and we detected chemokine (C-C motif) ligand-2 (CCL2) as one of downstream effectors of JunB. CCL2 plays a critical role in tumorigenesis in other types of cancer, but its role in ccRCC remains unclear. In this study, we invest...

Journal: :Journal of immunology 2006
Svetlana M Stamatovic Richard F Keep Marija Mostarica-Stojkovic Anuska V Andjelkovic

Although recent studies have suggested that CC chemokine CCL2 may directly affect the angiogenesis, the signaling events involved in such regulation remain to be determined. This study investigated a potential signal mechanism involved in CCL2-induced angiogenesis. Our in vitro and in vivo (hemangioma model of angiogenesis) experiments confirmed earlier findings that CCL2 can induce angiogenesi...

Journal: :Journal of Biomedicine and Biotechnology 2005
M. S. Brault R. A. Kurt

Monocyte chemoattractant protein-1 (MCP-1, CCL2) is produced by many different types of cells. In the current investigation, the effect of tumor-derived CCL2 on macrophages was evaluated to determine the extent to which this chemokine influenced the innate immune response to cancer. To do this, we used the 4T1 murine mammary carcinoma cell line that constitutively expresses CCL2 and generated 4...

2013
Antonia Marazioti Chrysoula A. Kairi Magda Spella Anastasios D. Giannou Sophia Magkouta Ioanna Giopanou Vassilios Papaleonidopoulos Ioannis Kalomenidis Linda A. Snyder Dimitrios Kardamakis Georgios T. Stathopoulos

Using genetic interventions, we previously determined that C-C motif chemokine ligand 2 (CCL2) promotes malignant pleural effusion (MPE) formation in mice. Here we conducted preclinical studies aimed at assessing the specific therapeutic potential of antibody-mediated CCL2 blockade against MPE. For this, murine MPEs or skin tumors were generated in C57BL/6 mice by intrapleural or subcutaneous d...

Journal: :بینا 0
طاهره محمدیان mohammadian university of tabriz, tabriz, iranدانشکده علوم طبیعی- دانشگاه تبریز- تچشم پزشکبریز- ایران مرتضی جبارپور بنیادی jabarpoor bonyadi university of tabrizدانشکده علوم طبیعی- دانشگاه علوم پزشکی تبریز و مرکز تحققات سلامت کودکان- دانشگاه علوم پزشکی تبریز- تبریز- ایران محمدحسین جبارپور بنیادی jabarpoor bonyadi university of tabrizقطب علمی تنوع زیستی- دانشگاه علوم پزشکی گناباد- گناباد- ایران حمید احمدیه ahmadieh university of tabrizمرکز تحقیقات چشم- دانشگاه شهید بهشتی- تهران- ایران زکیه یعقوبی yaghoobi university of tabrizدانشگاه علوم پزشکی گناباد- گناباد- ایران

purpose: to investigate the effect of ccl2c-2512t polymorphism on age-related macular degeneration (amd). methods: this study enrolled 48 patients originating from northeast of iran who suffered from dry type amd. the association of c-2518t in the promoter region of ccl2 gene was investigated using polymerase chain reaction (pcr) and restriction fragment length polymorphism (rflp). control grou...

2013
Ming Li Deborah A Knight Linda A Snyder Mark J Smyth Trina J Stewart

The chemokine CCL2, which is best known for its chemotactic functions, is expressed not only by immune cells, but also by several types of malignant and stromal cells. CCL2 has been shown to exert both pro- and anti-tumor effects. However, recent results demonstrate a main role for CCL2 in tumor progression and metastasis, suggesting that this chemokine may constitute a therapeutic target for a...

2014
Yaeli Lebel-Haziv Tsipi Meshel Gali Soria Adva Yeheskel Elad Mamon Adit Ben-Baruch

The chemokine CCL2 (MCP-1) has been identified as a prominent tumor-promoting factor in breast cancer. The major source for CCL2 is in the tumor cells; thus, identifying the mechanisms regulating CCL2 release by these cells may enable the future design of modalities inhibiting CCL2 secretion and consequently reduce tumorigenicity. Using cells deficient in expression of glycosaminoglycans (GAGs)...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید